购物车里没有产品

Anti-ISX/Intestine Specific Homeobox Antibody

产品货号 产品 品牌 单位 存货 价格 促销价 数量  
AB-06-2516
Anti-ISX/Intestine Specific Homeobox Antibody
洱畔/Erpan Tech 有货

产品特性        

Product Cat#: AB-06-2516
Product type: Primary antibody
Antigen: ISX/Intestine specific homeobox
Immunogen: Recombinant protein
Species immunized: Mouse
Isotype: IgG1
Applications: Western Blot (1:800-1:2000); Immunohistochemistry (1:80-1:200)
Reactivity: zebrafish and Human
Clonality (clone number): Monoclonal(A11-B4)
Form: Liquid
Buffer: Tris-HCl buffer (pH 7.4), 1% BSA, 40% glycerol, 0.05% NaN3.
Concentration: 1 mg/ml
Purity: Protein A affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: Cytosolic NADP isocitrate dehydrogenase antibody
Cytosolic NADP-isocitrate dehydrogenase antibody
Epididymis luminal protein 216 antibody
Epididymis secretory protein Li 26 antibody
HEL-216 antibody
HEL-S-26 antibody
ICDH antibody
IDCD antibody
IDH antibody
IDH1 antibody
IDHC_HUMAN antibody
IDP antibody
IDPC antibody
Isocitrate dehydrogenase [NADP] cytoplasmic antibody
Isocitrate dehydrogenase 1 (NADP+) soluble antibody
NADP dependent isocitrate dehydrogenase cytosolic antibody
NADP dependent isocitrate dehydrogenase peroxisomal antibody
NADP(+)-specific ICDH antibody
Oxalosuccinate decarboxylase antibody
PICD antibody
展开

靶标信息

Isocitrate dehydrogenase (IDH) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2. In humans, IDH exists in three isoforms: IDH3 catalyzes the third step of the citric acid cycle while converting NAD+ to NADH in the mitochondria. The isoforms IDH1 and IDH2 catalyze the same reaction outside the context of the citric acid cycle and use NADP+ as a cofactor instead of NAD+. They localize to the cytosol as well as the mitochondrion and peroxisome. Mutations in IDH1 are also implicated in cancer. Originally mutations in IDH1 were detected in an integrated genomic analysis of human glioblastoma multiforme. In addition to being mutated in diffuse gliomas, IDH1 has also been shown to harbor mutations in human acute myeloid leukemia (AML).

产品来源

洱畔科技实验室

文件下载

MSDS-AB-06-2516.pdf (下载86 )